Literature DB >> 9278443

Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen.

M L Finnis1, M A Gibson.   

Abstract

The interactions of type VI collagen have been investigated, using solid phase binding assays, with two components of the fibrillin-containing microfibrils, the elastin-binding protein, MAGP-1 and its structural relative MAGP-2. Both native and pepsin-treated forms of type VI collagen specifically bound to MAGP-1 but not to MAGP-2. Pepsin type VI collagen was shown to block the binding of MAGP-1 to native type VI collagen indicating that the major MAGP-1-binding site was in the triple-helical region of the molecule. MAGP-1 was found not to bind to collagens I, III, and V. Affinity blotting of pepsin-treated type VI collagen showed that MAGP-1 binding was specific for the collagenous domain of the alpha3(VI) chain. Decorin and biglycan were found not to inhibit the interaction of pepsin-treated type VI collagen with MAGP-1, indicating that its binding site on the collagen is not close to that for the proteoglycans. Reduction and alkylation of disulfide bonds in MAGP-1 did not destroy its type VI collagen-binding properties, indicating that the binding site was likely to be in the cysteine-free, N-terminal domain of MAGP-1. Interestingly, the interaction of MAGP-1 with type VI collagen was inhibited by tropoelastin, suggesting that the binding sites for tropoelastin and type VI collagen may be in the same domain of MAGP-1. A peptide, corresponding to amino acids 29-38 of MAGP-1, was found to inhibit the interactions of MAGP-1 with type VI collagen and tropoelastin. The results suggest that the peptide may contain the binding sequences for both type VI collagen and tropoelastin, and thus that these two proteins may share the same binding site on MAGP-1. The interactions of MAGP-1 with type VI collagen and tropoelastin were both determined to be of moderately high affinity, with Kd values of 5.6 x 10(-7) M and 2.6 x 10(-7) M, respectively. The findings indicate that MAGP-1 may mediate a molecular interaction between type VI collagen microfibrils and fibrillin-containing microfibrils, structures which are often found in close proximity to each other in a wide range of extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278443     DOI: 10.1074/jbc.272.36.22817

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 2.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Identification of the growth factor-binding sequence in the extracellular matrix protein MAGP-1.

Authors:  Thomas J Broekelmann; Nicholas K Bodmer; Robert P Mecham
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

Review 4.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

Review 5.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

6.  Characterization of metabolic health in mouse models of fibrillin-1 perturbation.

Authors:  Tezin A Walji; Sarah E Turecamo; Antea J DeMarsilis; Lynn Y Sakai; Robert P Mecham; Clarissa S Craft
Journal:  Matrix Biol       Date:  2016-02-21       Impact factor: 11.583

7.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

8.  Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.

Authors:  Claudio C Werneck; Cristina P Vicente; Justin S Weinberg; Adrian Shifren; Richard A Pierce; Thomas J Broekelmann; Douglas M Tollefsen; Robert P Mecham
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

9.  Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach.

Authors:  Stuart A Cain; Amanda McGovern; Elaine Small; Lyle J Ward; Clair Baldock; Adrian Shuttleworth; Cay M Kielty
Journal:  Mol Cell Proteomics       Date:  2009-09-15       Impact factor: 5.911

10.  Improvement of sciatic nerve regeneration using laminin-binding human NGF-beta.

Authors:  Wenjie Sun; Changkai Sun; Hui Zhao; Hang Lin; Qianqian Han; Jingyu Wang; Hui Ma; Bing Chen; Zhifeng Xiao; Jianwu Dai
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.